Procept preclinical data

PRCT said that preclinical data on its PIC-060 analogs shows in vitro activity and in vivo suppression of allograft transplant rejection. Data were presented at the International Conference on New Trends in Clinical and Experimental Immunosuppression in Geneva, Switzerland.

PRCT's PRO-2844B and PRO-1556 are ruthenium-based compounds with a mechanism of action distinct from cyclosporine. ...